Kevin Lustig, CEO of Assay Depot Inc., said the company has forged deals with two of the top 10 drug companies.

Kevin Lustig, CEO of Assay Depot Inc., said the company has forged deals with two of the top 10 drug companies. Photo by Melissa Jacobs.

Making a drug used to fall to Big Pharma, costing a billion dollars and requiring resources and lab space to boot...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129